Tumor-derived chemotactic factor(S) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues

✍ Scribed by B. Bottazzi; P. Ghezzi; G. Taraboletti; M. Salmona; N. Colombo; C. Bonazzi; C. Mangloni; A. Mantovani

• Publisher: John Wiley and Sons
• Year: 1985
• Tongue: French
• Weight: 714 KB
• Volume: 36
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.2910360207

✦ Synopsis

Abstract

Supernatants from freshly disaggregated human ovarian carcinomas maintained in vitro for 24 hr, from primary ovarian carcinoma cultures (4–6 days in culture) and from established ovarian cancer cell lines were examined for chemotactic activity on blood monocytes in blind‐well chemotaxis chambers. Tumor‐cell culture supernatants induced migration of peripheral blood monocytes across polycarbonate filters with considerable heterogeneity among different tumors. Induction of migration occurred only in the presence of a gradient between the lower and upper compartments of the chamber. Chemotactic activity was characterized by means of supernatants from primary ovarian carcinoma cultures. Chemotactic factor(s) was (were) produced in serum‐free conditions and the production was inhibited by emetine but not by mitomycin C. The activity was destroyed by exposure to proteolytic enzymes and by heating at 100°C but was unaffected by RNase, DNase, lipase and exposure to extreme pH values or heating at 56°C. Upon fractionation on Sephadex G 75, the activity eluted as a single peak in the cytochrome C region, corresponding to an apparent molecular weight of about 12 kd. The percentage of macrophages was assessed in 25 freshly disaggregated tumor specimens. Ovarian carcinomas were heterogeneous in their macrophage content with values ranging from 4 to 36%. A significant (r = 0.62; p = 0.00097), though far from absolute, correlation was found between chemotactic activity of culture supernatants and percentage of tumor‐associated macrophages. Tumor‐derived chemotactic factor(s) could be one of the mechanisms involved in the regulation of the macrophage content of human ovarian carcinomas.